BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kocan M, Sarwar M, Hossain MA, Wade JD, Summers RJ. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3). Br J Pharmacol 2014;171:2827-41. [PMID: 24641548 DOI: 10.1111/bph.12623] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Lin G, Feng Y, Cai X, Zhou C, Shao L, Chen Y, Chen L, Liu Q, Zhou Q, Bathgate RAD, Yang D, Wang MW. High-Throughput Screening Campaign Identified a Potential Small Molecule RXFP3/4 Agonist. Molecules 2021;26:7511. [PMID: 34946593 DOI: 10.3390/molecules26247511] [Reference Citation Analysis]
2 Kocan M, Ang SY, Summers RJ. Orthosteric, Allosteric and Biased Signalling at the Relaxin-3 Receptor RXFP3. Neurochem Res 2016;41:610-9. [PMID: 26294284 DOI: 10.1007/s11064-015-1701-3] [Reference Citation Analysis]
3 Praveen P, Kocan M, Valkovic A, Bathgate R, Hossain MA. Single chain peptide agonists of relaxin receptors. Molecular and Cellular Endocrinology 2019;487:34-9. [DOI: 10.1016/j.mce.2019.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
4 Kristensson L, Mayer G, Ploj K, Wetterlund M, Arlbrandt S, Björquist A, Wissing BM, Castaldo M, Larsson N. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology. Eur J Pharmacol 2015;747:123-31. [PMID: 25496752 DOI: 10.1016/j.ejphar.2014.11.041] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Albert-Gasco H, Sanchez-Sarasua S, Ma S, García-Díaz C, Gundlach AL, Sanchez-Perez AM, Olucha-Bordonau FE. Central relaxin-3 receptor (RXFP3) activation impairs social recognition and modulates ERK-phosphorylation in specific GABAergic amygdala neurons. Brain Struct Funct 2019;224:453-69. [PMID: 30368554 DOI: 10.1007/s00429-018-1763-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
6 Albert-Gascó H, García-Avilés Á, Moustafa S, Sánchez-Sarasua S, Gundlach AL, Olucha-Bordonau FE, Sánchez-Pérez AM. Central relaxin-3 receptor (RXFP3) activation increases ERK phosphorylation in septal cholinergic neurons and impairs spatial working memory. Brain Struct Funct 2017;222:449-63. [PMID: 27146679 DOI: 10.1007/s00429-016-1227-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
7 Kocan M, Sarwar M, Ang SY, Xiao J, Marugan JJ, Hossain MA, Wang C, Hutchinson DS, Samuel CS, Agoulnik AI, Bathgate RAD, Summers RJ. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1. Sci Rep 2017;7:2968. [PMID: 28592882 DOI: 10.1038/s41598-017-02916-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
8 Gay EA, Guan D, Van Voorhies K, Vasukuttan V, Mathews KM, Besheer J, Jin C. Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System. J Med Chem 2022. [PMID: 35594150 DOI: 10.1021/acs.jmedchem.2c00508] [Reference Citation Analysis]
9 Valkovic AL, Leckey MB, Whitehead AR, Hossain MA, Inoue A, Kocan M, Bathgate RAD. Real-time examination of cAMP activity at relaxin family peptide receptors using a BRET-based biosensor. Pharmacol Res Perspect 2018;6:e00432. [PMID: 30263124 DOI: 10.1002/prp2.432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Voglsanger LM, Read J, Ch'ng SS, Zhang C, Eraslan IM, Gray L, Rivera LR, Hamilton LD, Williams R, Gundlach AL, Smith CM. Differential Level of RXFP3 Expression in Dopaminergic Neurons Within the Arcuate Nucleus, Dorsomedial Hypothalamus and Ventral Tegmental Area of RXFP3-Cre/tdTomato Mice. Front Neurosci 2020;14:594818. [PMID: 33584175 DOI: 10.3389/fnins.2020.594818] [Reference Citation Analysis]
11 Halls ML, Bathgate RA, Sutton SW, Dschietzig TB, Summers RJ. International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides. Pharmacol Rev. 2015;67:389-440. [PMID: 25761609 DOI: 10.1124/pr.114.009472] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 12.9] [Reference Citation Analysis]
12 Praveen P, Bathgate RAD, Hossain MA. Engineering of chimeric peptides as antagonists for the G protein-coupled receptor, RXFP4. Sci Rep 2019;9:17828. [PMID: 31780677 DOI: 10.1038/s41598-019-53707-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Hojo K, Hossain MA, Tailhades J, Shabanpoor F, Wong LL, Ong-Pålsson EE, Kastman HE, Ma S, Gundlach AL, Rosengren KJ, Wade JD, Bathgate RA. Development of a Single-Chain Peptide Agonist of the Relaxin-3 Receptor Using Hydrocarbon Stapling. J Med Chem 2016;59:7445-56. [PMID: 27464307 DOI: 10.1021/acs.jmedchem.6b00265] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
14 Ang SY, Hutchinson DS, Evans BA, Hossain MA, Patil N, Bathgate RA, Kocan M, Summers RJ. The actions of relaxin family peptides on signal transduction pathways activated by the relaxin family peptide receptor RXFP4. Naunyn Schmiedebergs Arch Pharmacol 2017;390:105-11. [PMID: 27888281 DOI: 10.1007/s00210-016-1321-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
15 Hossain MA, Kocan M, Yao ST, Royce SG, Nair VB, Siwek C, Patil NA, Harrison IP, Rosengren KJ, Selemidis S, Summers RJ, Wade JD, Bathgate RAD, Samuel CS. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1. Chem Sci 2016;7:3805-19. [PMID: 30155023 DOI: 10.1039/c5sc04754d] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
16 Ch'ng SS, Fu J, Brown RM, Smith CM, Hossain MA, McDougall SJ, Lawrence AJ. Characterization of the relaxin family peptide receptor 3 system in the mouse bed nucleus of the stria terminalis. J Comp Neurol 2019;527:2615-33. [PMID: 30947365 DOI: 10.1002/cne.24695] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Ang SY, Hutchinson DS, Patil N, Evans BA, Bathgate RAD, Halls ML, Hossain MA, Summers RJ, Kocan M. Signal transduction pathways activated by insulin-like peptide 5 at the relaxin family peptide RXFP4 receptor. Br J Pharmacol 2017;174:1077-89. [PMID: 27243554 DOI: 10.1111/bph.13522] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
18 Guan D, Rahman MT, Gay EA, Vasukuttan V, Mathews KM, Decker AM, Williams AH, Zhan CG, Jin C. Indole-Containing Amidinohydrazones as Nonpeptide, Dual RXFP3/4 Agonists: Synthesis, Structure-Activity Relationship, and Molecular Modeling Studies. J Med Chem 2021;64:17866-86. [PMID: 34855388 DOI: 10.1021/acs.jmedchem.1c01081] [Reference Citation Analysis]
19 Reiter E, Ayoub MA, Pellissier LP, Landomiel F, Musnier A, Tréfier A, Gandia J, De Pascali F, Tahir S, Yvinec R, Bruneau G, Poupon A, Crépieux P. β-arrestin signalling and bias in hormone-responsive GPCRs. Mol Cell Endocrinol 2017;449:28-41. [PMID: 28174117 DOI: 10.1016/j.mce.2017.01.052] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]